| Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors (NCT00608803) | Alaunos Therapeutics | 2008-01-01 |
| A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001) (NCT00559182) | Merck Sharp & Dohme LLC | 2007-12-05 |
| Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients (NCT00610194) | Bayer | 2007-11-28 |
| A Study of LY2090314 in Patients With Advanced or Metastatic Cancer (NCT01287520) | Eli Lilly and Company | 2007-11-01 |
| Bevacizumab in Multiple Phase I Combinations (NCT00543504) | M.D. Anderson Cancer Center | 2007-10-10 |
| Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans (NCT00591890) | Alaunos Therapeutics | 2007-10-01 |
| A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients (NCT00551850) | AVEO Pharmaceuticals, Inc. | 2007-10-01 |
| Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas (NCT00591422) | Alaunos Therapeutics | 2007-08-01 |
| The Exceptional Patient in Cancer Care (NCT00543153) | M.D. Anderson Cancer Center | 2007-08-01 |
| Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases (NCT00513162) | M.D. Anderson Cancer Center | 2007-07-01 |
| Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies (NCT00629473) | Celgene | 2007-07-01 |
| A Study for Participants With Advanced Cancer (NCT01214629) | Eli Lilly and Company | 2007-07-01 |
| Valproic Acid and Bevacizumab in Patients With Advanced Cancer (NCT00530907) | M.D. Anderson Cancer Center | 2007-06-01 |
| Latent Tuberculosis Infection in Cancer Patients (NCT00507754) | M.D. Anderson Cancer Center | 2007-06-01 |
| Improving Clinician Communication Skills (ICCS) (NCT00687349) | University of Washington | 2007-04-01 |
| Fatigue Experience in Cancer Patients (NCT00450541) | M.D. Anderson Cancer Center | 2007-03-01 |
| MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED) (NCT00518739) | Merck Sharp & Dohme LLC | 2007-02-01 |
| Methylphenidate and a Nursing Telephone Intervention for Fatigue (NCT00424099) | M.D. Anderson Cancer Center | 2007-01-09 |
| Parenteral Hydration in Advanced Cancer Patients (NCT00423722) | M.D. Anderson Cancer Center | 2007-01-09 |
| Effects of Mirtazapine on Appetite in Advanced Cancer Patients (NCT00488072) | M.D. Anderson Cancer Center | 2007-01-08 |
| Gemcitabine and Dasatinib in Advanced Solid Tumors (NCT00429234) | M.D. Anderson Cancer Center | 2007-01-01 |
| Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer (NCT00408226) | CASI pharmaceuticals, Inc. | 2006-10-01 |
| The Feasibility of Physical Activity in Advanced Cancer Patients (NCT00438620) | AHS Cancer Control Alberta | 2006-10-01 |
| Olanzapine in Patients With Advanced Cancer and Weight Loss (NCT00489593) | M.D. Anderson Cancer Center | 2006-10-01 |
| Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies (NCT00629200) | M.D. Anderson Cancer Center | 2006-09-13 |
| Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer (NCT01538537) | Traws Pharma, Inc. | 2006-08-01 |
| Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer (NCT01538563) | Traws Pharma, Inc. | 2006-06-01 |
| Study of XIAP Antisense for Advanced Cancers (NCT00385775) | Aegera Therapeutics | 2006-06-01 |
| A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer (NCT00421135) | Alaunos Therapeutics | 2006-02-01 |
| Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors (NCT00708773) | University of Chicago | 2006-02-01 |
| A Study of ARRY-334543 in Patients With Advanced Cancer (NCT00278902) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2006-01-01 |
| Measuring Sleep Disturbance Among Cancer Patients (NCT00505544) | M.D. Anderson Cancer Center | 2005-08-01 |
| Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors (NCT00106626) | Merck Sharp & Dohme LLC | 2005-08-01 |
| A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007) (NCT00907738) | Merck Sharp & Dohme LLC | 2005-08-01 |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin (NCT00147225) | M.D. Anderson Cancer Center | 2005-08-01 |
| Cancer Patients' Medication Knowledge in the Emergency Center (NCT00385476) | M.D. Anderson Cancer Center | 2005-08-01 |
| Fatigue in Emergency Center Patients (NCT00504985) | M.D. Anderson Cancer Center | 2005-08-01 |
| Delirium Recall in Advanced Cancer Patients (NCT00493714) | M.D. Anderson Cancer Center | 2005-07-01 |
| Rapamycin in Advanced Cancers (NCT00707135) | University of Chicago | 2005-06-01 |
| Subcutaneous Olanzapine for Hyperactive or Mixed Delirium (NCT00512291) | M.D. Anderson Cancer Center | 2005-06-01 |
| Outcomes of Triaged Family Care in Advanced Cancer (NCT00709176) | University of Michigan | 2005-06-01 |
| An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer (NCT00214838) | Callisto Pharmaceuticals | 2005-03-01 |
| Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement (NCT00507962) | M.D. Anderson Cancer Center | 2005-03-01 |
| Measuring Hope and Hopelessness in Cancer (NCT00581880) | Memorial Sloan Kettering Cancer Center | 2005-01-01 |
| Study of Rapamycin Plus Ketoconazole in Advanced Cancers (NCT00708591) | University of Chicago | 2004-10-01 |
| Locus of Control and Spirituality in Palliative Care Patients (NCT00477243) | M.D. Anderson Cancer Center | 2004-06-03 |
| A Study of ARRY-142886 in Patients With Advanced Cancer (NCT00085787) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2004-06-01 |
| The Effect of Donepezil on Sedation and Other Symptoms (NCT00352664) | M.D. Anderson Cancer Center | 2003-11-01 |
| Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer (NCT01644968) | Providence Health & Services | 2003-11-01 |
| Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium) (NCT00951574) | Italfarmaco | 2003-10-01 |
| Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes (NCT00529230) | M.D. Anderson Cancer Center | 2001-12-11 |
| Individual Patient Compassionate Use of GX-I7 (NCT04289155) | Genexine, Inc. | |
| A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers (NCT02889445) | DEKK-TEC, Inc. | |
| Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation (NCT05162443) | Bristol-Myers Squibb | |
| Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors (NCT06872489) | Second Life Therapeutics | |